|
Don’t miss this opportunity to have your voice heard! FAST and ASF are finalizing the Voice of the Patient report, highlighting real-life experiences, challenges, and priorities of the Angelman community. The report will be submitted to the FDA and serve as an essential resource for researchers, drug developers, and regulators working to advance new treatments.
Your input will help ensure the Angelman community’s needs stay at the center of future progress.
Add your comments by May 8:
|